Source:http://linkedlifedata.com/resource/pubmed/id/16888916
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2006-8-7
|
pubmed:abstractText |
Anaplastic large cell lymphoma (ALCL) comprises approximately 25 % of all non-Hodgkin lymphomas in children and young adults. 40% of these tumours have a translocation t(2;5)(p23;q35), which fuses the nucleophosmin gene (NPM) to the anaplastic lymphoma kinase gene (ALK) resulting in a hybrid protein which contributes to the pathogenensis of ALCL. To further analyse the transforming activity in an animal model, a cDNA encoding the protein product, NPM-ALK, was incorporated into a retrovirus construct and introduced into mouse bone marrow progenitors by infection. In a bone marrow gene transfer and transplantation protocol the hematopoietic compartments of lethally irradiated IL-9 transgenic mice were reconstituted with npm-alk infected progenitor cells. IL-9 transgenic mice were chosen, because IL-9, a pleiotropic T helper 2 cytokine, is expressed in most cases of human ALCL and was shown to have an oncogenic potential at least on T cells. Reconstituted mice developed NPM-ALK positive lymphomas including lymphoblastic lymphomas of T-cell type (T-LB), mature and immature plasmacytoma (PZ) and plasmoblastic/anaplastic diffuse large B-cell lymphoma after 10-30 weeks. The combined overexpression of NPM-ALK and IL-9 exerts cooperative oncogenic activity in the transformation of murine lymphoid cells leading to accelerated and enhanced development of T-LB. Many animals developed plasmacytic/plasmoblastic neoplasms, of which the most aggressive tumours share many features with human anaplastic/plasmoblastic diffuse large B-cell lymphoma.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0070-4113
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
224-31
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16888916-Animals,
pubmed-meshheading:16888916-Bone Marrow Transplantation,
pubmed-meshheading:16888916-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16888916-Gene Transfer Techniques,
pubmed-meshheading:16888916-Humans,
pubmed-meshheading:16888916-Interleukin-9,
pubmed-meshheading:16888916-Lymphoma, T-Cell,
pubmed-meshheading:16888916-Mice,
pubmed-meshheading:16888916-Mice, Transgenic,
pubmed-meshheading:16888916-Oncogene Proteins, Fusion,
pubmed-meshheading:16888916-Protein-Tyrosine Kinases
|
pubmed:year |
2003
|
pubmed:articleTitle |
[Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice].
|
pubmed:affiliation |
Institut für Pathologie der Universität S-H, Lübeck.
|
pubmed:publicationType |
Journal Article,
English Abstract
|